Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

DR. AGARWAL'S HEALTH CARE LTD.

NSE : AGARWALEYEBSE : 544350ISIN CODE : INE943P01029Industry : Hospital & Healthcare ServicesHouse : Private

BSE411.504.35 (+1.07 %)

PREV CLOSE ( ) 407.15

OPEN PRICE ( ) 405.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 13130

TODAY'S LOW / HIGH ( )402.95 414.60

52 WK LOW / HIGH ( )327.4 463.85

NSE411.754.4 (+1.08 %)

PREV CLOSE( ) 407.35

OPEN PRICE ( ) 404.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 411.75 (256)

VOLUME 289279

TODAY'S LOW / HIGH( ) 402.15 414.95

52 WK LOW / HIGH ( )327 464

Select year

(Rs.in Million)

Particulars

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Mar 2020

Profit Before Tax

1405.68

835.91

567.63

-483.51

-108.03

Adjustment

2328.90

1974.03

1381.72

1452.33

1392.01

Changes In working Capital

45.94

-125.05

-150.11

97.72

-88.12

Cash Flow after changes in Working Capital

3780.52

2684.89

1799.24

1066.54

1195.86

Cash Flow from Operating Activities

3459.58

2331.06

1643.28

991.59

1032.93

Cash Flow from Investing Activities

-9138.61

-5090.85

-1553.51

-365.69

-797.46

Cash Flow from Financing Activities

5526.71

3033.39

354.33

-371.07

-734.95

Net Cash Inflow / Outflow

-152.32

273.60

444.10

254.83

-499.48

Opening Cash & Cash Equivalents

1269.81

996.21

552.11

386.57

942.43

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

-89.27

-56.39

Closing Cash & Cash Equivalent

1117.49

1269.81

996.21

552.12

386.57